Skip to main content
Equibles

TD PRIVATE CLIENT WEALTH LLC

Position in BMRN — Biomarin Pharmaceutical Inc

CIK 1551017 NEW YORK, NY
Back to BMRN Full portfolio

Position in BMRN

as of Jun 30, 2026 · filed Aug 4, 2026
Position Value
$5,092
+$4,923 QoQ
Shares Held
89
+2866.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#492
of 561 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in BMRN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TD PRIVATE CLIENT WEALTH LLC holds $2,696,000 across 45 Biotechnology names. BMRN ranks #20 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 EXEL
Exelixis, Inc.
 13,440 $731,270
2 JAZZ
Jazz Pharmaceuticals plc
 2,863 $689,897
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,361 $676,049
4 GMAB
Genmab A/S
 4,376 $120,208
5 REGN
Regeneron Pharmaceuticals, Inc.
 150 $93,531
6 MRNA
Moderna, Inc.
 1,305 $91,389
7 INSM
INSMED Inc
 517 $55,122
8 ARGX
Argenx SE
 28 $25,977

All Filings in BMRN

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,092 89
2026-03-31 $169 3
2025-12-31 $178 3
2025-06-30 $27,704 504
2025-03-31 $48,210 682
2024-12-31 $41,804 636
2024-09-30 $35,847 510
2024-06-30 $26,674 324
2024-03-31 $21,747 249
2023-12-31 $13,595 141
2023-09-30 $10,352 117
2023-06-30 $9,188 106
2023-03-31 $7,779 80
2022-12-31 $6,830 66
2022-09-30 $4,747 56
2022-06-30 $4,640 56
2022-03-31 $4,317 56
2021-12-31 $6,184 70
2021-09-30 $3,091 40
2021-06-30 $4,005 48
2021-03-31 $2,793 37
2020-12-31 $1,929 22
2020-09-30 $1,369 18
2020-06-30 $986 8
2020-03-31 $2,957 35

Report a Problem

Category
Description
Email (optional, for follow-up)